19-55156590-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000363.5(TNNI3):​c.150+13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 1,560,062 control chromosomes in the GnomAD database, including 2,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 1127 hom., cov: 32)
Exomes 𝑓: 0.0089 ( 1014 hom. )

Consequence

TNNI3
NM_000363.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: -0.0510

Publications

3 publications found
Variant links:
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
TNNI3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • cardiomyopathy, familial restrictive, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1FF
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AR, AD Classification: STRONG Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 19-55156590-C-T is Benign according to our data. Variant chr19-55156590-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 43362.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.226 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000363.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNNI3
NM_000363.5
MANE Select
c.150+13G>A
intron
N/ANP_000354.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNNI3
ENST00000344887.10
TSL:1 MANE Select
c.150+13G>A
intron
N/AENSP00000341838.5P19429
ENSG00000267110
ENST00000587871.1
TSL:5
n.*252+13G>A
intron
N/AENSP00000473050.1M0R381
TNNI3
ENST00000665070.1
c.150+13G>A
intron
N/AENSP00000499482.1A0A590UJN1

Frequencies

GnomAD3 genomes
AF:
0.0682
AC:
10376
AN:
152084
Hom.:
1120
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0307
Gnomad ASJ
AF:
0.00662
Gnomad EAS
AF:
0.00482
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.00288
Gnomad OTH
AF:
0.0522
GnomAD2 exomes
AF:
0.0181
AC:
3057
AN:
169018
AF XY:
0.0146
show subpopulations
Gnomad AFR exome
AF:
0.236
Gnomad AMR exome
AF:
0.0146
Gnomad ASJ exome
AF:
0.00672
Gnomad EAS exome
AF:
0.00355
Gnomad FIN exome
AF:
0.000314
Gnomad NFE exome
AF:
0.00287
Gnomad OTH exome
AF:
0.0136
GnomAD4 exome
AF:
0.00887
AC:
12493
AN:
1407860
Hom.:
1014
Cov.:
33
AF XY:
0.00795
AC XY:
5527
AN XY:
695280
show subpopulations
African (AFR)
AF:
0.239
AC:
7669
AN:
32046
American (AMR)
AF:
0.0175
AC:
650
AN:
37062
Ashkenazi Jewish (ASJ)
AF:
0.00676
AC:
172
AN:
25436
East Asian (EAS)
AF:
0.00161
AC:
59
AN:
36722
South Asian (SAS)
AF:
0.00436
AC:
349
AN:
80116
European-Finnish (FIN)
AF:
0.000543
AC:
27
AN:
49762
Middle Eastern (MID)
AF:
0.0250
AC:
142
AN:
5682
European-Non Finnish (NFE)
AF:
0.00203
AC:
2193
AN:
1082678
Other (OTH)
AF:
0.0211
AC:
1232
AN:
58356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
594
1187
1781
2374
2968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0684
AC:
10415
AN:
152202
Hom.:
1127
Cov.:
32
AF XY:
0.0659
AC XY:
4902
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.230
AC:
9531
AN:
41468
American (AMR)
AF:
0.0306
AC:
468
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00662
AC:
23
AN:
3472
East Asian (EAS)
AF:
0.00483
AC:
25
AN:
5178
South Asian (SAS)
AF:
0.00787
AC:
38
AN:
4830
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10618
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.00288
AC:
196
AN:
68032
Other (OTH)
AF:
0.0554
AC:
117
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
417
834
1250
1667
2084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0312
Hom.:
155
Bravo
AF:
0.0790
Asia WGS
AF:
0.0550
AC:
192
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
Hypertrophic cardiomyopathy (3)
-
-
2
not provided (2)
-
-
1
Cardiomyopathy (1)
-
-
1
Cardiomyopathy, familial restrictive, 1 (1)
-
-
1
Dilated cardiomyopathy 2A (1)
-
-
1
Dilated Cardiomyopathy, Recessive (1)
-
-
1
Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome (1)
-
-
1
Familial restrictive cardiomyopathy (1)
-
-
1
Hypertrophic cardiomyopathy 7 (1)
-
-
1
Primary ciliary dyskinesia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.3
DANN
Benign
0.63
PhyloP100
-0.051
PromoterAI
-0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73617692; hg19: chr19-55667958; API